These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36 related articles for article (PubMed ID: 18972109)
1. Population pharmacokinetic model-based dosing proposal for ampicillin prophylaxis in cardiac surgery patients with cardiopulmonary bypass. Urbánek K; Šantavý P; Zuščich O; Kubíčková V; Michaličková D; Slanař O; Šíma M J Chemother; 2023 Nov; 35(7):614-622. PubMed ID: 36715134 [TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic modeling of sufentanil in adult Korean patients undergoing cardiopulmonary bypass surgery. Khaowroongrueng V; Son KH; Lee SM; Lee J; Park CG; Lee SI; Shin D; Shin KH CPT Pharmacometrics Syst Pharmacol; 2024 Jul; ():. PubMed ID: 39039947 [TBL] [Abstract][Full Text] [Related]
3. Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety. Kim JH; Shim JK; Song JW; Song Y; Kim HB; Kwak YL Crit Care; 2013 Oct; 17(5):R254. PubMed ID: 24156702 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model. Anderson GD; Peterson TC; Vonder Haar C; Kantor ED; Farin FM; Bammler TK; Macdonald JW; Hoane MR Front Pharmacol; 2013; 4():129. PubMed ID: 24151467 [TBL] [Abstract][Full Text] [Related]
5. Effect of cardiopulmonary bypass on cytochrome P450 enzyme activity: implications for pharmacotherapy. Adiraju SKS; Shekar K; Fraser JF; Smith MT; Ghassabian S Drug Metab Rev; 2018 May; 50(2):109-124. PubMed ID: 29254370 [TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetic profile of recombinant human erythropoietin is unchanged in patients undergoing cardiac surgery. McCluskey SA; Cheung WK; Katznelson R; Poonawala H; Fedorko L; Djaiani G; Mehta B; Karkouti K Eur J Clin Pharmacol; 2009 Mar; 65(3):273-9. PubMed ID: 18972109 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of one large dose of erythropoietin against cardiac and cerebral ischemic injury occurring during cardiac surgery with cardiopulmonary bypass: a randomized double-blind placebo-controlled pilot study. Joyeux-Faure M; Durand M; Bedague D; Protar D; Incagnoli P; Paris A; Ribuot C; Levy P; Chavanon O Fundam Clin Pharmacol; 2012 Dec; 26(6):761-70. PubMed ID: 21929528 [TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin. Xenocostas A; Cheung WK; Farrell F; Zakszewski C; Kelley M; Lutynski A; Crump M; Lipton JH; Kiss TL; Lau CY; Messner HA Eur J Clin Pharmacol; 2005 May; 61(3):189-95. PubMed ID: 15776276 [TBL] [Abstract][Full Text] [Related]
9. Intraoperative vancomycin pharmacokinetics in cardiac surgery with or without cardiopulmonary bypass. Cotogni P; Passera R; Barbero C; Gariboldi A; Moscato D; Izzo G; Rinaldi M Ann Pharmacother; 2013 Apr; 47(4):455-63. PubMed ID: 23512663 [TBL] [Abstract][Full Text] [Related]
10. Two large preoperative doses of erythropoietin do not reduce the systemic inflammatory response to cardiac surgery. Poulsen TD; Andersen LW; Steinbrüchel D; Gøtze JP; Jørgensen OS; Olsen NV J Cardiothorac Vasc Anesth; 2009 Jun; 23(3):316-23. PubMed ID: 18948032 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats. Yoon WH; Park SJ; Kim IC; Lee MG Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of epoetin alfa in critically ill patients. Corwin HL; Gettinger A; Fabian TC; May A; Pearl RG; Heard S; An R; Bowers PJ; Burton P; Klausner MA; Corwin MJ; N Engl J Med; 2007 Sep; 357(10):965-76. PubMed ID: 17804841 [TBL] [Abstract][Full Text] [Related]